Cipolletti, M.; Bartoloni, S.; Busonero, C.; Parente, M.; Leone, S.; Acconcia, F.
A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. Int. J. Mol. Sci. 2021, 22, 2915.
https://doi.org/10.3390/ijms22062915
AMA Style
Cipolletti M, Bartoloni S, Busonero C, Parente M, Leone S, Acconcia F.
A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. International Journal of Molecular Sciences. 2021; 22(6):2915.
https://doi.org/10.3390/ijms22062915
Chicago/Turabian Style
Cipolletti, Manuela, Stefania Bartoloni, Claudia Busonero, Martina Parente, Stefano Leone, and Filippo Acconcia.
2021. "A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells" International Journal of Molecular Sciences 22, no. 6: 2915.
https://doi.org/10.3390/ijms22062915
APA Style
Cipolletti, M., Bartoloni, S., Busonero, C., Parente, M., Leone, S., & Acconcia, F.
(2021). A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells. International Journal of Molecular Sciences, 22(6), 2915.
https://doi.org/10.3390/ijms22062915